Engineering Tissues and Organs: The Road to the Clinic
With recent advances in both gene editing and stem cell biology, the promise of cellular therapies is now closer than ever. Clinical trials for the application of chimeric antigen receptor T cells has driven an enormous investment into the development of such cellular products and learnings from these emboldening investors and engaging regulators across the globe.